ArticleCancer reports (Hoboken, N.J.)2020

Retinoic acid receptor γ is a therapeutically targetable driver of growth and survival in prostate cancer.

Kevin Petrie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.